Notably, there was a decreasing trend in the use of rivaroxaban with worsening renal function, observed in patients with CKD with stage 3a (14.9% of initiations by 2020), stage 3b (9.2%) and stage 4 (5.9%).
← all excerpts
Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010-2020.
1
—
—